ImpediMed Future Growth

How is ImpediMed forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

Future Growth Score

5/6

Future Growth Score 5/6

78.9%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

ASX:IPD - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2025	68	8	16	11	1
6/30/2024	40	-5	-4	-5	2
6/30/2023	23	-14	-18	-12	2
6/30/2022	11	-20	-21	-16	N/A
3/31/2022	10	-20	-19	-14	N/A
12/31/2021	10	-19	-17	-13	N/A
9/30/2021	9	-20	-16	-13	N/A
6/30/2021	8	-21	-16	-13	N/A
3/31/2021	7	-20	-17	-15	N/A
12/31/2020	6	-19	-18	-16	N/A
9/30/2020	6	-20	-20	-18	N/A
6/30/2020	6	-21	-21	-19	N/A
12/31/2019	5	-25	-22	-20	N/A
9/30/2019	5	-24	-22	-20	N/A
6/30/2019	4	-24	-22	-20	N/A
12/31/2018	4	-25	-23	-21	N/A
9/30/2018	3	-26	-24	-22	N/A
6/30/2018	3	-27	-25	-23	N/A
3/31/2018	4	-28	N/A	N/A	N/A
12/31/2017	4	-28	-26	-26	N/A
9/30/2017	5	-28	-26	-26	N/A
6/30/2017	6	-28	-26	-26	N/A
3/31/2017	6	-28	-25	-25	N/A
12/31/2016	6	-29	-25	-25	N/A
9/30/2016	6	-27	-24	-24	N/A
6/30/2016	6	-26	-23	-22	N/A
3/31/2016	6	-23	N/A	-19	N/A

Earnings vs Savings Rate: IPD is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).

Earnings vs Market: IPD is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: IPD is expected to become profitable in the next 3 years.

Revenue vs Market: IPD's revenue (53.1% per year) is forecast to grow faster than the Australian market (3.5% per year).

High Growth Revenue: IPD's revenue (53.1% per year) is forecast to grow faster than 20% per year.

Future ROE: IPD's Return on Equity is forecast to be low in 3 years time (15.7%).